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Evaluation of aid to diagnosis of pigmented skin lesions
in general practice: controlled trial randomised by practice
Dallas R English, Robert C Burton, Chris B del Mar, Robert J Donovan, Paul D Ireland, Geoff Emery
Abstract
Objectives To determine whether an aid to the
diagnosis of pigmented skin lesions reduces the ratio
of benign lesions to melanomas excised in general
practice.
Design Controlled trial randomised by practice.
Setting General practices in Perth, Western Australia.
Participants 468 general practitioners in 223
practices.
Interventions Intervention practices were given an
algorithm and instant camera to assist with the
diagnosis of pigmented skin lesions. All practices were
given national guidelines on managing melanoma.
Main outcome measures Ratio of benign pigmented
lesions to melanomas excised. Analyses conducted
with and without inclusion of seborrhoeic keratoses.
Results At baseline the ratios of benign to malignant
lesions were lower in the intervention group than in
the control group. During the trial period the ratios
were higher in the intervention group (19:1 v 17:1
without seborrhoeic keratoses and 29:1 v 26:1 with
seborrhoeic keratoses). After adjustment for patients’
age, sex, and socioeconomic status, the ratio was 1.02
times higher (95% confidence interval 0.68 to 1.51,
P = 0.94) in the intervention group when seborrhoeic
keratoses were not included and 1.03 times higher
(0.71 to 1.50, P = 0.88) when seborrhoeic keratoses
were included. General practitioners in the
intervention group were less likely than those in the
control group to excise the most recent pigmented
skin lesion they managed (22% v 48%, P < 0.001) and
to refer the patient to a specialist (16% v 27%,
P = 0.06).
Conclusions Provision of the algorithm and camera
did not decrease the ratio of benign pigmented skin
lesions to melanomas excised by general practitioners.
Introduction
Doctors are anxious not to miss melanomas because
early diagnosis is associated with good prognosis.1 2 A
melanoma screening trial with Australian general
practitioners showed high sensitivity (0.95, 95%
confidence interval 0.90 to 1.0) for the diagnosis of
melanoma but low specificity (0.49, 95% confidence
interval 0.41 to 0.57).3 Low specificity and low
prevalence of melanoma, even in Australian general
practice, means that for every melanoma excised
between 10 and 28 benign naevi are excised; this rises
to 35 if seborrhoeic keratoses are included.4–7 Similar
ratios have been found elsewhere.8 Thus, reducing the
number of benign pigmented skin lesions removed
without decreasing sensitivity would reduce unneces-
sary surgery.
A trial of an algorithm and instant camera to
improve general practitioners’ skills in diagnosing pig-
mented skin lesions was conducted in two provincial
cities in Queensland, Australia. The rationale was that
patients would be reassured if steps are taken to check
that a pigmented lesion shows no change.6 In the six
months before the trial, the ratios of benign lesions to
melanomas excised in the two cities were similar, but
the ratio was significantly lower in the intervention city
after the intervention. The number of melanomas
excised in the intervention city, however, was higher
during the intervention period than the baseline
period. We replicated this intervention in urban
general practice in Australia, using a controlled trial
that randomised by general practice rather than by city.
Methods
General practitioners on the mailing lists of the
divisions of general practice (geographically based
groups with some similarities to UK primary care
groups) in Perth were eligible. They had to agree to
their practice being randomised and to pathology
laboratories releasing data on pigmented skin lesions
that they excised. None were planning to retire or relo-
cate in the next 12 months or were already using
equipment to monitor pigmented skin lesions. General
practitioners who joined a practice after random-
isation or with whom we had had no contact before
randomisation (usually because the mailing lists were
incomplete) were also eligible. In Australia general
practitioners often work at multiple practices. Those
who did so could participate at each practice, though
they were asked to follow the protocol allocated to that
practice.
During the randomisation visit, all practices were
given national guidelines on managing melanoma.9
Randomisation occurred after the trial was explained
and the doctors present had consented. The research
assistants then gave doctors in the intervention group
the aid to diagnosis and trained them to use it. The aid
included an algorithm slightly modified from the
original (fig 1)6 and an instant camera (Polaroid Spec-
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tra AF, Polaroid Australia Pty Ltd, North Ryde, NSW)
with stand and film. The algorithm centres on change
in appearance as a key to distinguishing melanomas
from benign lesions.10 The doctors were informed that
the aid did not replace normal clinical responsibility.
We used a computer generated randomisation
code consisting of random permuted blocks and strati-
fied by practice size (one, two to three, and four or
more general practitioners). A programmer prepared
the codes and sealed them in envelopes that were
labelled with the practice size. After randomisation,
participants and research assistants who visited
practices were not blinded to assignment. All coding of
outcome data was done blind to assignment.
Evaluation was based on the ratio of benign to
malignant pigmented skin lesions excised. We defined
a malignant lesion as an in situ or invasive melanoma
and a benign lesion as a naevus (including dysplastic
naevus) or (in some analyses) a seborrhoeic keratosis.
We included seborrhoeic keratoses because they are
commonly mistaken for melanomas.7 All pathology
reports on excisions of pigmented skin lesions from
1 November 1998 to 31 August 2000 were obtained
from pathology laboratories.
At the end of the study we sent the general practi-
tioners a questionnaire on how they had managed
their last three patients with pigmented skin lesions.
Because the management of the three lesions was
similar we have reported information relating only to
the last lesion.
Statistical analysis
The primary analysis was based on comparisons
between groups. For consistency with the earlier trial6
we did not include seborrhoeic keratoses in this analy-
sis. Lesions were counted only if they were excised by a
participating doctor at a study practice. Because not all
doctors in each practice took part in the trial we could
do a strict intention to treat analysis. If practices
merged we used data until the date of the merger.
We used logistic regression with generalised
estimating equations and the sandwich estimator of the
variance to analyse data on individual lesions, allowing
for the clustering by practice.11 12 Odds ratios, their 95%
confidence intervals, and Wald test P values were
obtained from these models. The odds ratio was calcu-
lated as the ratio of benign to malignant lesions in the
intervention group divided by the ratio in the control
group.
All models included practice size and the patient’s
age, sex, and socioeconomic status. Age was analysed in
four groups ( < 30, 30-39, 40-54, and ≥ 55 years).
Socioeconomic status was estimated from the patient’s
postcode and grouped into approximate quarters.13
Data for these covariates were missing for eight lesions
(of 3822) in the trial period and four (of 4741) in the
baseline period.
Four secondary analyses of the primary outcome
were undertaken. Firstly, we included seborrhoeic
keratoses. These lesions were included in all subse-
quent secondary analyses. Secondly, we excluded
doctors who joined the trial after practices were
randomised. Thirdly, we excluded five “specialist” gen-
eral practitioners to whom other doctors refer patients
with pigmented skin lesions because these specialists
performed a substantial proportion of all excisions and
four were in the intervention group. Fourthly, we tested
an interaction between intervention group and the
patient’s age, which might modify any effect of the
intervention because of its inclusion in the algorithm
(fig 1).
To assess the effect of the intervention on the num-
bers of lesions excised (including seborrhoeic kera-
toses), we calculated the annual number of excisions
for each practice and grouped them into categories
(melanomas: 0, > 0 and < 1, 1, 2, ≥ 3; benign lesions: 0,
> 0 and < 5, 5-12, 13-27, 28-49, 50-99, ≥ 100). (The
category of > 0 covers those practices that excised one
melanoma in a period of over one year; therefore they
had excised more than none in one year but less than
one.) We used Pearson’s correlation coefficients to esti-
mate changes within each intervention group between
the baseline and trial periods and performed all analy-
ses in Stata/SE 7.0 (StataCorp, College Station, TX,
USA).
Calculations of sample size
Seborrhoeic keratoses were not included in the sample
size calculations. We assumed that the ratio of benign
to malignant lesions in the control group would be 23,
which was the baseline average in the Queensland trial.
The trial had 80% power (P = 0.05, two sided) to detect
a 36% lower ratio in the intervention group during the
trial period.
General practitioners in the Queensland trial (pro-
vincial cities with greater ratios of general practitioners
to patients) excised 27 pigmented lesions per year; we
estimated that general practitioners in Perth (a city of
1.2 million people) would remove 16.2 per year (60%
of 27). We assumed that the intraclass correlation
within practices for the diagnosis of melanoma was
0.015. We estimated that the maximum we could
recruit was 450 general practitioners, or about 225
practices with two doctors per practice. To achieve 80%
power required nine months of follow up. No interim
analyses were planned or performed.
Patient with suspicious naevus
Check for change
Arrange
excision
Reassure patient
and discharge
Review at
6 months
Photograph and 
review in 4-8 weeks
Are you certain
that this is
a melanoma?
Are you certain
that this is not
a melanoma?Still suspicious
or patient
>40 years?
• Size (spreading)?
• Outline (notched, indented,irregular)?
• Darker (overall, variegation)?
• Elevation?
• Surface change (bleeding, ulceration,
  crusting)?
• Daughter lesions?
• Tingling or itching?
Yes
No
Yes
Yes
No
NoYes
Fig 1 Algorithm to assist with the management of patients with
pigmented skin lesions
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Results
Participation and randomisation
We identified 488 practices, of which 223 participated
(fig 2). Practices were randomised between 14 Septem-
ber 1999 and 8 February 2000. The two groups had
similar durations of baseline and trial periods and were
similar in terms of total general practitioners per prac-
tice and the number that participated within each
practice (table 1). The intervention group had slightly
more practices in areas of highest socioeconomic
status, and the control group had slightly more
practices in the middle two quarters.
We identified 1221 GPs, of whom 468 participated
in the trial (fig 2). Fourteen GPs working at more than
one practice participated at multiple practices. Of
these, five GPs (one women and four men) worked at
multiple practices that were allocated to both groups.
More GPs working at intervention practices partici-
pated in the study, which was partly due to more GPs in
intervention practices joining the trial after the
practice was randomised (fig 2). The control group
included 81 women (37%) and the intervention group
91 women (36%).
Similar numbers of GPs in the two groups left their
practices during the trial (fig 2). No other GPs
withdrew from the trial. However, only 302 (65%) GPs
completed the questionnaire at the end of the study
(fig 2).
Excision of pigmented skin lesions
During the two periods, the participants excised 8563
pigmented skin lesions: 295 (3%) melanomas (180
invasive and 115 in situ), 529 (6%) dysplastic naevi,
5065 (59%) other naevi, and 2674 (31%) seborrhoeic
keratoses. The ratio of benign lesions to melanomas
was 19 without and 28 with seborrhoeic keratoses.
More than half the lesions were excised from females
(4878, 57%) and almost half (3928, 46%) were from
patients less than 40 years of age. The number of exci-
sions per practice ranged from none (42 practices) to
more than 1000, with a median of 15. The number of
melanomas varied from none (130 practices) to 31
with a median of 0.
During the baseline period, the two groups had
similar annual numbers of excisions of benign lesions
and melanomas within practices (table 2). Overall, the
intervention group excised more melanomas and
488 practices invited to join study (1221 GPs)
223 practices agreed to take part
(500 GPs expressed interest)
Control practices
112 (228 GPs)
Intervention practices
111 (245 GPs)
11 GPs did not attend training
16 GPs withdrew at training session
5 GPs excluded:
  3 had already used cameras
  1 planned to retire
  1 would not be randomised
265 practices declined (721 GPs)
223 randomised practices
 (stratified by practice size) (468 GPs)
458 GPs total in 112 practices*
  231 took part
  56 joined after practice randomised
  6 left their only trial practice
  1 left control practice but remained at
    intervention practice
  1 practice merged with intervention
    practice
33 practices had no excisions
Median (interquartile range) excisions = 6 (0–20)
ICC = 0.005 (<0.001 after adjustment for patients'
  age, sex, and socioeconomic status)
2224 patient encounters with 2715 excisions
  (1867 had 1 only)
Baseline period 20 practices had no excisions
Median (interquartile range) excisions = 9 (2–21)
ICC = 0.005 (<0.001 after adjustment for patients'
  age, sex, and socioeconomic status)
1771 patient encounters with 2026 excisions
  (1573 had 1 only)
32 practices had no excisions
Median (interquartile range) excisions = 3 (0–17)
ICC = 0.007 (<0.001 after adjustment for patients'
  age, sex, and socioeconomic status)
1713 patient encounters with 2051 excisions
  (1457 had 1 only)
Trial period
Excisions of pigmented
skin lesions
22 practices had no excisions
Median (interquartile range) excisions = 7 (1–19)
ICC = 0.004 (0.003 after adjustment for patients'
  age, sex, and socioeconomic status)
1537 patient encounters with 1771 excisions
  (1360 had 1 only)
155 (63%) GPs 147 (64%) GPsGP questionnairre
on management
410 GPs total in 111 practices*
  251 took part
  67 joined after practice randomised
  7 left their only trial practice
  1 left from one intervention practice,
    stayed at 2nd intervention practice
  1 left intervention practice but stayed
    at control practice
  1 practice merged with control practice
Fig 2 Flow diagram for practices, general practitioners, and excised pigmented skin lesions based on practices. *General practitioners counted
once at each practice whereas all others counted once only in each group (ICC=intraclass correlation)
Table 1 Characteristics of practices in each group. Figures are numbers (percentage) of
practices unless stated otherwise
Control (n=112) Intervention (n=111)
No of doctors in practice*:
1 22 (20) 27 (24)
2-3 33 (29) 32 (29)
≥4 57 (51) 52 (47)
No of doctors in study at each practice:
1 56 (50) 49 (44)
2-3 39 (35) 41 (37)
≥4 17 (15) 21 (19)
Index of socioeconomic status of practice location:
1st quarter (highest) 22 (20) 31 (28)
2nd quarter 30 (27) 26 (23)
3rd quarter 31 (28) 26 (23)
4th quarter (lowest) 29 (26) 28 (25)
Mean (SD) length of period (days):
Baseline 365 (32.3) 364 (32.6)
Intervention 305 (32.3) 306 (32.6)
*Practice size determined from census taken during randomisation visit.
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more benign lesions and had more favourable ratios of
benign lesions to melanomas (table 3). The apparent
inconsistency between the figures within practices and
the overall totals was due to the imbalance in specialist
general practitioners (four of the total (five) were in the
intervention group). When we excluded these GPs, the
number of excisions of benign lesions was similar in
the two groups, although the intervention group
excised more melanomas and therefore had a lower
ratio of benign to malignant lesions (table 3).
Neither group showed substantial changes in the
excision rates within practices between the baseline
and trial periods (table 2), and the correlation
coefficients for the categorised rates in each group
before and after randomisation were small and not sig-
nificant (intervention group: benign lesions r = –0.01
(P = 0.9), melanomas r = –0.01 (P = 0.9); control
group: benign lesions r = –0.01 (P = 0.9), melanomas r
= 0.07 (P = 0.3)). The overall rates showed little change
in the control group, but decreased in the intervention
group between periods (table 3), largely because of
substantial reductions in a few practices with large
numbers of baseline excisions (data not shown).
The intervention group had a slightly higher ratio
of benign lesions to melanomas during the trial period
(table 3). After adjustment for practice size and
patients’ age, sex, and socioeconomic status, the odds
ratio from the primary analysis was close to unity. Its
confidence interval was consistent with at most about
32% lower ratio of benign to malignant lesions in the
intervention group (table 2). The interaction between
intervention group and patients’ age was not
significant (P = 0.71). The odds ratios were similar for
all secondary analyses (table 3).
Compliance and reported management of
pigmented skin lesions
We provided intervention practices with 482 packets of
film (4820 possible photographs), and 85 practices
requested at least one additional packet of film during
the trial.
One hundred and twenty (82%) control GPs and
131 (85%) intervention GPs who returned the
questionnaire reported that they had dealt with at least
one pigmented lesion during the trial, though four of
these doctors gave no details on their management.
One hundred and thirty (84%) intervention GPs
reported that they photographed at least one patient.
The median number of patients photographed was
eight.
When we asked about the last patient with a
pigmented lesion that they managed, GPs in the inter-
vention group reported that they referred fewer
patients to specialists, photographed more lesions, and
excised fewer lesions (table 4). When patients were
referred, there was little difference between the groups
in choice of specialist (table 4; P = 0.45).
Discussion
The provision of a camera and algorithm to general
practitioners to help them manage patients with suspi-
cious pigmented lesions did not decrease the ratio of
benign lesions to melanomas they excised. During the
trial period, the ratio was actually slightly higher in the
intervention group. There was some evidence, albeit
not significant, that the intervention group excised
fewer melanomas during the trial period, raising the
possibility that some melanomas were missed.
How valid are these results? Chance is unlikely to
explain the apparent lack of effect on the ratio of
benign to malignant lesions as the lower bound of the
confidence interval for the primary analysis (0.68)
excludes strong effects and is barely consistent with the
32% lower ratio of benign to malignant lesions in the
intervention group of the previous trial.6
The ratio of benign to malignant lesions was lower
in the intervention group before randomisation, which
Table 2 Number (percentage) of excisions per year of benign pigmented skin lesions
(including seborrhoeic keratoses) and melanomas performed in each practice during
baseline and trial periods, by trial group
Excisions per
year
Baseline period Trial period
Control Intervention Control Intervention
Benign pigmented skin lesions:
0 20 (18) 33 (30) 22 (20) 32 (29)
<5 20 (18) 19 (17) 18 (16) 28 (25)
5-12 24 (21) 19 (17) 34 (30) 16 (14)
13-27 26 (23) 18 (16) 15 (13) 13 (12)
28-49 12 (11) 9 (8) 12 (11) 10 (9)
50-99 8 (7) 8 (7) 9 (8) 7 (6)
≥100 2 (2) 5 (5) 2 (2) 5 (5)
Melanomas:
0 81 (72) 74 (67) 79 (71) 82 (74)
<1* 10 (9) 8 (7) 0 0
1 8 (7) 15 (14) 17 (15) 15 (14)
2 7 (6) 4 (4) 10 (9) 6 (5)
≥3 6 (5) 10 (9) 6 (5) 8 (7)
*Occurred when practices excised one lesion in period of over one year (such as one in 14 months) and
therefore annual rate was >0 but <1.
Table 3 Odds ratios and confidence intervals for analysis of benign pigmented skin lesions and melanomas
Control Intervention
Odds ratio* (95% CI) P valueBenign Melanoma Ratio Benign Melanoma Ratio
Excisions in baseline period
Excluding seborrhoeic keratoses 1345 61 22 1805 100 18 0.82 (0.60 to 1.13)
Including seborrhoeic keratoses 1965 61 32 2615 100 26 0.79 (0.57 to 1.09)
Excluding specialist GPs† 1788 51 35 1716 67 26 0.70 (0.45 to 1.09)
Excisions in trial period
Excluding seborrhoeic keratoses 1361‡ 79 17 1559 81 19 1.02 (0.68 to 1.51) 0.94
Including seborrhoeic keratoses 2037 79 26 2369 81 29 1.03 (0.71 to 1.50) 0.88
Excluding specialist GPs† 1803 72 25 1562 57 27 1.06 (0.70 to 1.61) 0.78
Excluding GPs who joined trial after
practice was randomised†
1737 63 28 2279 76 30 0.99 (0.67 to 1.47) 0.98
*Adjusted for practice size and patients’ age, sex, and socioeconomic status.
†Analysis includes seborrhoeic keratoses.
‡Numbers in trial period are numbers excised per year for comparison with baseline period.
Primary care
page 4 of 6 BMJ VOLUME 327 16 AUGUST 2003 bmj.com
 on 14 November 2007 bmj.comDownloaded from 
should have favoured finding a lower ratio during the
trial period. Exclusion of the specialist general
practitioners, most of whom were in the intervention
group, had no impact on the results. Although more
GPs in the intervention group joined the trial after
their practice was randomised, their exclusion also had
little effect. All analyses were adjusted for patient char-
acteristics that might affect the ratio of benign lesions
to melanoma—namely, age, sex, and socioeconomic
status.
Compliance seemed high, as indicated by use of
film and general practitioners’ reports on the number
of patients that they photographed. Our objective evi-
dence on number of excisions by the intervention
general practitioners suggests that most practices
showed little change, but that in practices where there
were many excisions before baseline, there was a
reduction. We do not know what proportion of this
change was due to the intervention rather than to
regression to the mean. Some contamination might
have been present because five general practitioners
were in both groups, but fewer doctors in the control
group reported photographing skin lesions, and in
the control group excision rates were similar before
and after randomisation.
How do we reconcile the results from this trial with
those from the previous apparently successful one?6
The design and settings of the two trials were different.
Our design is stronger because we randomised
multiple practices rather than two cities. It was
conducted in a metropolitan rather than a remote pro-
vincial setting, where there was only one dermatologist.
Perth has numerous specialists in skin diagnosis to
whom general practitioners could refer patients. We
had no objective data on referrals to specialists,
although general practitioners in the intervention
group reported that they were less likely to refer
patients in the trial period. Perhaps it is more common
for general practitioners to refer diagnostically
worrying lesions to such services in Perth, in which
case we might have been measuring the wrong sort of
lesion. Despite these differences, there is no obvious
explanation for the discrepancy.
We had few eligibility criteria that would limit the
external validity of the study. GPs particularly
interested in skin lesions may have been more likely to
participate, but the ratios that we observed were similar
to that found in an analysis of all excisions sent to a
pathology service in Victoria.7 GPs in Australia practise
on a fee for service basis, and excisions of malignant
skin lesions attract a higher payment than excisions of
benign skin lesions. Our results may not be applicable
to general practice in places where methods of
remuneration differ or where melanomas are uncom-
mon. The results are not relevant to other aids to the
diagnosis of pigmented skin lesions such as dermatos-
copy14 nor to whole body photography of patients with
multiple atypical naevi.15 16
In conclusion, our results do not show that photo-
graphy of pigmented skin lesions in general practice in
Australia decreases the number of benign lesions
excised without compromising sensitivity of the
diagnosis of melanoma.
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